JY
ANAC

Jeff Yass’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Jeff Yass’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-239,600
Closed -$12.8M – 10167
2016
Q1 		$12.8M Sell
239,600
-95,900
-29% -$7.08M 0.01% 1331
2015
Q4 		$37.9M Buy
335,500
+130,700
+64% +$14.4M 0.02% 747
2015
Q3 		$24.1M Sell
204,800
-230,000
-53% -$30M 0.01% 1061
2015
Q2 		$33.7M Buy
434,800
+252,700
+139% +$16.6M 0.01% 920
2015
Q1 		$10.5M Buy
182,100
+107,300
+143% +$4.56M ﹤0.01% 1828
2014
Q4 		$2.41M Sell
74,800
-187,900
-72% -$5.64M ﹤0.01% 4096
2014
Q3 		$6.43M Buy
262,700
+145,200
+124% +$2.95M ﹤0.01% 2662
2014
Q2 		$2.08M Buy
117,500
+70,000
+147% +$1.13M ﹤0.01% 4585
2014
Q1 		$950K Buy
47,500
+25,900
+120% +$502K ﹤0.01% 5603
2013
Q4 		$362K Sell
21,600
-24,000
-53% -$332K ﹤0.01% 7272
2013
Q3 		$484K Buy
45,600
+34,400
+307% +$301K ﹤0.01% 6478
2013
Q2 		$63K Buy
+11,200
New +$67.8K ﹤0.01% 7929

Other funds holding ANAC

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Jeff Yass's ANAC Position: Q2 2016 in Review

Jeff Yass sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 101,038 shares — an estimated $5.4M sold.

Jeff Yass first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Jeff Yass reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Jeff Yass sold 101,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.4M.
  • Jeff Yass first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Jeff Yass's ANACOR PHARMACEUTICALS INC COM position peaked at $37.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.